Hydrating Toner & Essence for Dehydrated Skin: Low-Viscosity HA & Penetration Booster

Overview #

Dehydrated skin is not a skin type. It’s a condition — and the distinction matters when you’re writing a brief. Most brands come to us asking for “a hydrating toner,” but what they actually need depends on whether the barrier is intact, whether the skin is oily-dehydrated, and what claims they want to make in their target market. We’ve formulated low-viscosity hydration products across all three — EU, US, and NMPA — and the regulatory and clinical requirements are different enough that a single formula rarely satisfies all three without adjustment. The actives we reach for most often are hyaluronic acid (HA), niacinamide, and panthenol, and each has a meaningfully different evidence base. This article walks through what the clinical data actually shows, where we think it’s strong, and where we’re still not fully convinced.

The Clinical Evidence Behind the Three Actives We Use Most #

Hyaluronic Acid #

The HA story is well-documented, but the details matter more than most brands realize. The most relevant head-to-head data for topical low-molecular-weight HA (LMW-HA, typically 5–50 kDa) versus high-molecular-weight HA (HMW-HA, 1,000–1,800 kDa) comes from a split-face, double-blind RCT (n=33, 8 weeks) published in the Journal of Drugs in Dermatology. LMW-HA showed a 28% improvement in skin hydration measured by corneometry, versus 19% for HMW-HA. Both were applied at 2% w/w in an aqueous serum base, twice daily. The difference is real but not dramatic. What the study doesn’t capture — and what we’ve learned from our own batches — is that LMW-HA is significantly more irritating at concentrations above 1% in compromised barrier skin. We’ve had two client projects where the brief called for 2% LMW-HA and we had to walk it back after consumer panel feedback at the pilot stage.

For toners specifically, we typically formulate at 0.5–1.0% total HA with a blend of molecular weights. The penetration story for LMW-HA is real, but it’s not magic. At 5 kDa, you’re getting intercellular diffusion into the upper stratum corneum. You’re not reaching the dermis topically. Brands that claim “deep dermal hydration” from a topical HA toner are in claim substantiation territory that we’d push back on.

Niacinamide #

Niacinamide has one of the cleaner evidence bases of any cosmetic active. A randomized, double-blind, vehicle-controlled study (n=50, 12 weeks, twice-daily application at 5% concentration) showed a 24% reduction in transepidermal water loss (TEWL) and a statistically significant improvement in skin barrier function assessed by tape-stripping. The mechanism is well-understood: niacinamide upregulates ceramide synthesis and free fatty acid production in keratinocytes. That’s why it works in dehydrated skin even when the primary issue is barrier dysfunction rather than water content.

In our lab, we stabilize niacinamide at pH 5.5–6.5. Below pH 5.0, you start getting hydrolysis to nicotinic acid, which causes flushing in a meaningful percentage of users — roughly 10–15% based on our internal panel data. Above pH 7.0, the same conversion happens via a different pathway. This is usually where projects go sideways when a brand wants to combine niacinamide with a low-pH vitamin C system. Short answer: don’t try to combine these two in the same phase at the same pH.

Panthenol (Pro-Vitamin B5) #

Panthenol is the one we probably undervalue in briefs. It converts to pantothenic acid in the skin, which is a cofactor in fatty acid synthesis — so the mechanism overlaps with niacinamide but through a different pathway. A controlled clinical study (n=22, 4 weeks, 1% panthenol in aqueous gel, once daily) measured a 17% improvement in skin hydration by corneometry and a 12% reduction in TEWL versus vehicle. Modest numbers, but the tolerability profile is essentially zero-concern. We’ve never had a panthenol-related adverse event in any batch we’ve produced.

The practical value of panthenol in a toner formula is partly the efficacy and partly the sensory. At 1–3%, it adds a slight slip that improves spreadability without increasing viscosity meaningfully. For low-viscosity formats — watery essences, mist toners — that’s genuinely useful.

Evidence Strength Comparison: What the Data Actually Supports #

Beta-glucan is worth a note here. We’re still not fully convinced the independent clinical evidence is strong enough to support premium positioning on its own. Most of the data we’ve seen is supplier-funded, and the effect sizes are real but not consistently replicated in independent labs. We use it, but we don’t lead with it in claim strategy conversations.

For regulatory reference on evidence standards, the EU Cosmetics Regulation 1223/2009 Article 20 sets the framework for cosmetic claims substantiation in Europe, and it’s stricter than most brands expect on the word “clinically proven.”

Penetration Boosters: What We Actually Add and Why #

This is the section most toner briefs skip entirely, and it’s a mistake. A hydrating active sitting on the surface of the stratum corneum is doing something, but it’s not doing as much as it could. The penetration enhancer question is where we spend a lot of time in formulation.

The options we reach for most often in low-viscosity formats are: propylene glycol (PG) at 3–5%, butylene glycol (BG) at 3–8%, and niacinamide itself (which has mild penetration-enhancing properties at 5%). For brands that want to avoid glycols entirely — and we get this brief more often now, especially from EU clean beauty clients — the alternatives are more limited. Pentylene glycol at 1–3% works reasonably well and has a cleaner consumer perception. Ethoxydiglycol is effective but sits in a grey zone for some clean beauty standards.

Honestly, most brands underestimate how much the penetration enhancer affects the sensory profile. BG at 8% gives a noticeably different skin feel than PG at 5%, even in a watery formula. We’ve had clients reject a formula on sensory grounds that was performing well in hydration testing, and the culprit was always the glycol selection.

One failure case worth sharing: we had a project where the brand requested a “glycol-free, alcohol-free” watery essence with 1% LMW-HA and 5% niacinamide. The formula was stable at lab scale (500g batches). At 200kg production scale, we saw phase separation in 3 out of 10 bulk containers by week 6 of stability testing. The root cause was the absence of any glycol-class humectant to maintain water activity uniformity across the bulk. We reformulated with 2% pentylene glycol and the issue resolved. It’s not a perfect solution — the brand had to update their “glycol-free” claim — but it was the right call.

See our technical notes on waterless and concentrated formats for related formulation constraints when pushing actives to higher concentrations.

Where Most Brands Get the Claim Strategy Wrong #

EU, US, and NMPA have meaningfully different expectations for hydration claims, and we see brands get caught out on this regularly.

In the EU, under EU Cosmetics Regulation 1223/2009 and the associated Common Criteria Regulation (EC) No 655/2013, claims must be substantiated by evidence that is “adequate and verifiable.” For a claim like “clinically proven to hydrate for 24 hours,” you need a study with your actual finished formula, not just ingredient-level data. We’ve seen brands submit supplier dossiers for HA and get rejected by EU distributors who ask for finished-product testing. The SCCS Scientific Opinion framework is also relevant here if you’re making any claims that approach therapeutic territory.

In the US, the FDA Cosmetics Guidelines draw the line at drug claims. “Moisturizes skin” is cosmetic. “Repairs the skin barrier” starts to sound like a drug claim depending on context. “Treats dry skin” is a drug claim. We almost always push back on briefs that use the word “repair” in the US claim set — not because it’s always wrong, but because it triggers a conversation with the brand’s regulatory team that slows down launch timelines.

NMPA is the most demanding of the three for new actives. Under the NMPA Cosmetic Regulation framework updated in 2021, any ingredient not on the approved list requires a new ingredient registration that can take 3–4 years. For standard HA, niacinamide, and panthenol, you’re fine — all three are on the approved list. But if a brand wants to add a novel peptide or a proprietary ferment to the formula, the NMPA pathway adds significant time and cost. We now require clients to confirm their target markets before we finalize the active selection, because the NMPA constraint has killed more than one project late in development.

For stability testing protocols that underpin claim substantiation across all three markets, we follow ICH Stability Guidelines as a baseline, adapted for cosmetic formats.

Formulation Notes for Brand Partners #

What market? What are you expecting on-pack? Those are the first two questions we ask when a toner or essence brief comes in, because the answers change almost everything about the formula architecture.

If you’re targeting EU and want to make a “clinically proven hydration” claim, budget for finished-product testing — typically a corneometry study with n=20 minimum, 4–8 weeks, run by an independent CRO. That adds roughly 8–12 weeks to your development timeline and $8,000–$15,000 in testing costs depending on the CRO. If you’re targeting NMPA, confirm your active list against the approved ingredient catalogue before we start formulation — not after.

For the formula itself: a standard low-viscosity hydrating toner from our line runs at pH 5.5–6.0, with 0.5–1.0% total HA (blended MW), 5% niacinamide, 1% panthenol, and 3–5% butylene glycol as the primary penetration enhancer and humectant. Preservative system is typically phenoxyethanol at 0.8–1.0% with ethylhexylglycerin at 0.3%, which keeps us well within EU Cosmetics Regulation 1223/2009 Annex V limits and passes challenge testing to ISO 11930 criteria.

Packaging matters more than most brands expect for this format. A watery essence in a standard open-neck bottle will fail preservative challenge faster than the same formula in an airless or pump format. We’ve seen this repeatedly. If the brand wants a dropper or open-pour format, we adjust the preservative loading accordingly. See our broader hydration and moisture formulation resources at Hydration & Moisture for format-specific guidance.

MOQ for this category typically starts at 1,000 units. Airless pump packaging adds $0.40–$0.70 per unit at that MOQ, which is worth flagging early if the brand is working to a tight COGS target.

Frequently Asked Questions #

Q: We want to put “1% hyaluronic acid” on the pack — is that actually doing anything at that concentration?

Yes, but the molecular weight matters more than the percentage. At 1% HMW-HA, you’re getting surface hydration and a good skin feel. At 0.5% LMW-HA (5–50 kDa), you’re getting measurable intercellular penetration into the stratum corneum. We’d actually recommend a blend — 0.5% HMW for immediate feel, 0.3% LMW for deeper hydration — rather than 1% of a single grade.

Q: Can we combine niacinamide and vitamin C in the same toner?

We get this brief constantly. The short answer is: at pH 5.5–6.0 with ascorbyl glucoside or sodium ascorbyl phosphate as the vitamin C source, yes, it’s stable. With L-ascorbic acid at the pH you need for efficacy (below 3.5), no — the niacinamide will hydrolyze and you’ll get nicotinic acid flushing in a portion of your users. We’ve run the stability data on this combination at pH 3.2 and the niacinamide conversion starts within 4 weeks at 40°C. See our Vitamin C & Antioxidant Systems technical notes for the full compatibility matrix.

Q: How long does a hydration claim need to be substantiated for — 8 hours, 24 hours?

Depends on the market and the claim. In the EU, “long-lasting hydration” without a time qualifier is generally acceptable with a standard corneometry study showing improvement at 2 hours and 8 hours post-application. “24-hour hydration” requires a measurement at the 24-hour timepoint — obvious, but we’ve seen brands assume the 8-hour data covers it. For NMPA, the claim language needs to match the approved claim categories exactly; “持久保湿” (long-lasting moisturization) is an approved category, but the supporting data requirements are specified in the 2021 guidelines.

Q: What’s the minimum order quantity for a custom toner formula?

Our standard MOQ is 1,000 units for a custom formula in this category. Development fee is separate and covers formulation, stability initiation (3-month accelerated at 40°C/75% RH), and challenge testing to ISO 11930. If you need finished-product clinical testing for claim substantiation, that’s scoped separately with a CRO partner.

Q: We’ve seen “fermented HA” on competitor products — is there a real difference?

Honestly, the clinical differentiation is thin. Fermented HA (typically produced via Streptococcus zooepidemicus fermentation) is the standard production method for most pharmaceutical and cosmetic HA anyway — so the “fermented” label is partly marketing. Where there is a real difference is in the presence of co-produced metabolites from the fermentation broth, which some suppliers claim have additional skin-conditioning benefits. We’re not convinced the independent evidence supports a meaningful premium claim over standard HA at equivalent molecular weight and concentration. If a brand wants to use it, we can source it, but we’d be transparent with them about the evidence gap.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.